Cargando…
Randomized feasibility trial to assess tolerance and clinical effects of lithium in progressive multiple sclerosis
BACKGROUND: Disability accumulation in progressive multiple sclerosis (MS) results from inflammatory and neurodegenerative mechanisms. In animal models of MS, lithium acts to reduce inflammatory demyelination, and in models of neurodegenerative diseases, lithium also slows neuronal death. Prospectiv...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393418/ https://www.ncbi.nlm.nih.gov/pubmed/32760832 http://dx.doi.org/10.1016/j.heliyon.2020.e04528 |